Controversy over estrogen after Covaxin in Brazil, 1 bribe per dose

– Brazil has the first covexin. A deal with India Biotech was suspended for

New Delhi Date. Thursday, July 01, 2021

After the Covacin vaccine, the Brazilian government is now surrounding the estrogen vaccine. According to Brazilian media reports, there may also be irregularities in the purchase of AstraZeneca vaccine. According to a report, the Bolshevik government demanded a bribe for each dose of the AstraZeneca vaccine.

According to a Brazilian newspaper, a bribe of US$1 per dose of the AstraZeneca vaccine has been demanded. However, AstraZeneca has denied these claims. The company says that it does not work with any middlemen in Brazil. All agreements are made directly through Fiocruz (Osvaldo Cruz Foundation) and the federal government.

Dawati Medical Supplies reportedly asked for a portfolio of 400 million doses of the AstraZeneca vaccine, each dose costing $3.5 million. A single dose later cost 15.5. 1 bribe is being claimed for 40 crore doses

Covexin deal suspended

Brazil had earlier suspended a deal with India Biotech for Covaxin. In Brazil, such questions were being raised on this deal that the contract of 32.32 crores was suspended. According to the allegation, the deal for the expensive vaccine was done under pressure from the Health Ministry.

President Zaire Bolsonaro has been the talk of the town since news of the deal broke out in Brazil. A parliamentary panel is also probing Koro’s management and the issue was raised against him. The question was that even though Brazil had the option of buying the Pfizer vaccine, it bought the expensive vaccine from Bharat Biotech.

Back to top button